🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to clarify the impact of rituximab on clinical...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2011-08
Trial ID
NCT01448096
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
Laminoplasty and laminectomy are useful surgical procedures for the managem...
Status
Completed
Location
Beijing Tiantan Hospital
Start Date
2020-07-31
Trial ID
NCT04493463
Treatments Being Tested
Without therapy HLH is often fatal, and often rapidly fatal. The treatment ...
Status
Completed
Location
Childhood Cancer Research Unit, Karolinska Hospital
Start Date
2004-01
Trial ID
NCT00426101
Treatments Being Tested
* Replacement of intrathecal Triple (methotrexate, cytarabine, prednisolone...
Status
Suspended
Location
Department of Pediatrics, Rigshospitalet
Start Date
2009-01
Trial ID
NCT00991744
Treatments Being Tested
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB 2015 STUDY 1. Will the new risk group s...
Status
Unknown
Location
prof. R.O.Eolyan Hematology Center
Start Date
2015-11
Trial ID
NCT03390387
This research is being done to evaluate tazemetostat in combination with CH...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-24
Trial ID
NCT06692452
Treatments Being Tested
Quizartinib is an experimental drug. It is not approved for regular use. It...
Status
Active Not Recruiting
Location
Loma Linda University Cancer Center
Start Date
2018-08-15
Trial ID
NCT03793478
Treatments Being Tested